---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-25-000037"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2025-04-02T23:59:59+00:00"
generated_at: "2026-05-23T23:18:25.073597+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Regenerex Pharma appoints Kenneth Perry as CFO; Brent Wilson resigns effective March 31, 2025

## Summary
- Kenneth W. Perry appointed CFO effective March 31, 2025; 39 years of healthcare finance experience.
- Brent Wilson resigned as CFO on March 31, 2025, citing personal reasons.
- Perry holds an MBA in Finance from Mississippi State and a BS in Accounting from Tennessee Tech.
- Previously served as Division CFO for HCA and founded Lasis Healthcare; multiple award-winning CFO.

## SEC filing metadata
- accession: 0001472375-25-000037
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2025-04-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237525000037/0001472375-25-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237525000037/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-25-000037
- JSON: https://secwatch.observer/filing/0001472375-25-000037.json
- Plain text: https://secwatch.observer/filing/0001472375-25-000037.txt

## Key facts
- Executive change
  Brent Wilson resigned as Chief Financial Officer at REGENEREX PHARMA, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Effective March 31, 2025, Mr. Brent Wilson resigned his position as Chief Financial Officer of the Company due to personal reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237525000037/0001472375-25-000037-index.htm
- Executive change
  Kenneth W. Perry was appointed as Chief Financial Officer at REGENEREX PHARMA, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective March 31, 2025, Mr. Kenneth W. Perry has been appointed to serve as Chief Financial Officer for the company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237525000037/0001472375-25-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.